EVO

Evotec SE - ADR

3.54

USD

EVO Earnings Reports

Positive Surprise Ratio

EVO beat 15 of 37 last estimates.

41%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Evotec SE - ADR earnings per share and revenue

On Nov 05, 2025, EVO reported earnings of -0.12 USD per share (EPS) for Q3 25, missing the estimate of -0.11 USD, resulting in a -3.27% surprise. Revenue reached 163.89 million, compared to an expected 180.43 million, with a -9.17% difference. The market reacted with a -15.74% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Evotec SE - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Evotec SE - ADR reported EPS of -$0.12, missing estimates by -3.27%, and revenue of $163.89M, -9.17% below expectations.

How did the market react to Evotec SE - ADR's Q3 2025 earnings?

The stock price moved down -15.74%, changed from $3.97 before the earnings release to $3.35 the day after.

When is Evotec SE - ADR expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Evotec SE - ADR's next earnings report?

Based on -- analysts, Evotec SE - ADR is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.